BR0208103A - Composição para a prevenção de osteoporose compreendendo uma combinação de isoflavonas e ácidos graxos poliinsaturados - Google Patents
Composição para a prevenção de osteoporose compreendendo uma combinação de isoflavonas e ácidos graxos poliinsaturadosInfo
- Publication number
- BR0208103A BR0208103A BR0208103-2A BRPI0208103A BR0208103A BR 0208103 A BR0208103 A BR 0208103A BR PI0208103 A BRPI0208103 A BR PI0208103A BR 0208103 A BR0208103 A BR 0208103A
- Authority
- BR
- Brazil
- Prior art keywords
- polyunsaturated fatty
- isoflavones
- combination
- fatty acids
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 7
- 208000001132 Osteoporosis Diseases 0.000 title abstract 4
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 title abstract 3
- 235000008696 isoflavones Nutrition 0.000 title abstract 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 150000002515 isoflavone derivatives Chemical class 0.000 title abstract 2
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 abstract 2
- ZWSNUPOSLDAWJS-QNDFHXLGSA-N 6,7-dihydroxy-3-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound OC[C@H]1O[C@@H](Oc2ccc(cc2)-c2coc3cc(O)c(O)cc3c2=O)[C@H](O)[C@@H](O)[C@@H]1O ZWSNUPOSLDAWJS-QNDFHXLGSA-N 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 229930003448 Vitamin K Natural products 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 235000007882 dietary composition Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 abstract 1
- 235000006539 genistein Nutrition 0.000 abstract 1
- 229940045109 genistein Drugs 0.000 abstract 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 abstract 1
- 230000011164 ossification Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- 150000003710 vitamin D derivatives Chemical class 0.000 abstract 1
- 235000019168 vitamin K Nutrition 0.000 abstract 1
- 239000011712 vitamin K Substances 0.000 abstract 1
- 150000003721 vitamin K derivatives Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
- 229940046010 vitamin k Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Birds (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01106520 | 2001-03-15 | ||
EP01106520.8 | 2001-03-15 | ||
PCT/EP2002/002646 WO2002074308A1 (en) | 2001-03-15 | 2002-03-11 | Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0208103A true BR0208103A (pt) | 2004-03-02 |
BRPI0208103B1 BRPI0208103B1 (pt) | 2018-02-14 |
BRPI0208103B8 BRPI0208103B8 (pt) | 2021-05-25 |
Family
ID=8176795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0208103-2 BRPI0208103B8 (pt) | 2001-03-15 | 2002-03-11 | composição para a prevenção de osteoporose compreendendo uma combinação de isoflavonas e ácidos graxos poliinsaturados, seu uso, composição dietética, bem como formulação galênica que compreende a dita composição dietética |
Country Status (12)
Country | Link |
---|---|
US (1) | US7635692B2 (pt) |
EP (3) | EP1370257B1 (pt) |
JP (1) | JP4646491B2 (pt) |
KR (1) | KR100875800B1 (pt) |
CN (1) | CN100389765C (pt) |
AT (1) | ATE367810T1 (pt) |
BR (1) | BRPI0208103B8 (pt) |
CA (1) | CA2440261C (pt) |
DE (1) | DE60221367T2 (pt) |
ES (1) | ES2289097T3 (pt) |
MX (1) | MXPA03008137A (pt) |
WO (1) | WO2002074308A1 (pt) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109527538A (zh) * | 2018-11-07 | 2019-03-29 | 云南金霓尔生物科技有限公司 | 一种治疗骨质疏松促进吸收的营养剂及其制备方法 |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050090457A1 (en) * | 2002-02-15 | 2005-04-28 | N.V. Nutricia | Method of treating mammals with genistein and/or genistein analogues |
ITMI20022723A1 (it) * | 2002-12-20 | 2004-06-21 | Marfarma S R L Ora Marfarma Holding Spa | Composizioni per il trattamento della sindrome post-menopausa. |
KR101573316B1 (ko) * | 2004-03-29 | 2015-12-01 | 와이어쓰 엘엘씨 | 종합비타민 및 무기물 영양 보충제 |
CN100351248C (zh) * | 2004-07-05 | 2007-11-28 | 南京大学 | 染料木素衍生物及其制法和用途 |
US7601370B2 (en) | 2004-07-28 | 2009-10-13 | Abbott Laboratories | Method for controlling body weight in estrogen-insufficient women |
WO2006087164A1 (en) | 2005-02-15 | 2006-08-24 | Dsm Ip Assets B.V. | Compositions containing polysaccharides |
WO2006088418A1 (en) * | 2005-02-18 | 2006-08-24 | Core Competence Sweden Ab | A composition comprising a powder containing microencapsulated polyunsaturated long-chain esterified fatty acids distributed in an effervescent base |
US8242100B2 (en) * | 2006-02-28 | 2012-08-14 | Nestec Sa | Compositions and methods for inducing bone growth and inhibiting bone loss |
CA2643973A1 (en) * | 2006-02-28 | 2007-09-07 | Council Of Scientific And Industrial Research | Pharmaceutical composition containing butea isoflavones for the prevention /treatment of bone disorders and a process for the preparation thereof |
EP2004169B1 (en) | 2006-04-12 | 2012-08-08 | Unilever PLC | Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin |
ES2393212T3 (es) * | 2006-04-12 | 2012-12-19 | Unilever N.V. | Composición oral con un efecto antienvejecimiento sobre la piel |
EP2004161B8 (en) * | 2006-04-12 | 2013-04-17 | Unilever PLC | Oral composition comprising dha and genistein for enhancing skin properties |
WO2007128461A1 (en) * | 2006-05-10 | 2007-11-15 | Dsm Ip Assets B.V. | Animal food composition comprising genistein and polyunsaturated fatty acids |
US20070298079A1 (en) * | 2006-06-26 | 2007-12-27 | Tropicana Products, Inc. | Food fortified with omega-3 fatty acids |
PL2046312T3 (pl) * | 2006-07-14 | 2021-02-08 | Kaydence Pharma As | Produkty farmaceutyczne i nutraceutyki zawierające witaminę K2 |
EP1897530A1 (en) * | 2006-09-08 | 2008-03-12 | DSMIP Assets B.V. | Skin care composition |
WO2008119544A1 (en) | 2007-04-02 | 2008-10-09 | Dsm Ip Assets B.V. | Novel use of genistein |
US8211947B2 (en) * | 2008-01-28 | 2012-07-03 | Guillermo Selman-Housein Sosa | Composition and method for treating and preventing musculoskeletal and connective tissue disorders |
CN101537170B (zh) * | 2008-03-17 | 2012-05-30 | 哈药集团制药六厂 | 一种预防骨质疏松和骨关节病的组合物 |
CN101574338B (zh) * | 2008-05-05 | 2012-01-11 | 上海医药工业研究院 | 一种抑制芳香化酶活性的药物组合物及其应用 |
DE202009018772U1 (de) * | 2008-06-03 | 2013-03-15 | John Ray Biffin | Zusammensetzung enthaltend Vitamin K und ihre Verwendung |
TR201004464A2 (tr) * | 2010-06-03 | 2012-11-21 | B�Lg�� Mahmut | Kemik erimesi için formülasyon. |
CN102356877A (zh) * | 2011-10-14 | 2012-02-22 | 李泼 | Cbp养钙冲剂 |
WO2013089654A1 (en) * | 2011-12-16 | 2013-06-20 | Mahmut Bilgic | Effervescent formulations comprising genistein |
FR3005419B1 (fr) | 2013-05-13 | 2015-09-04 | Agronomique Inst Nat Rech | Utilisation d'une association de deux composes pour le traitement et/ou la prevention de troubles osseux |
WO2016099495A1 (en) * | 2014-12-17 | 2016-06-23 | Hill's Pet Nutrition, Inc. | Method and composition for reducing hyperthyroidism |
CN112401066B (zh) * | 2020-11-18 | 2022-10-28 | 乖宝宠物食品集团股份有限公司 | 一种利于维持骨骼健康的宠物食品 |
CN112790278B (zh) * | 2021-01-22 | 2022-10-28 | 乖宝宠物食品集团股份有限公司 | 一种维持骨骼健康的全价宠物罐头食品 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04253908A (ja) * | 1990-12-28 | 1992-09-09 | Nippon Oil & Fats Co Ltd | 骨粗鬆症治療薬 |
GB9112052D0 (en) * | 1991-06-05 | 1991-07-24 | Efamol Holdings | Fatty acid treatment |
GB9217780D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
DE19503190A1 (de) * | 1995-02-01 | 1996-08-08 | Dietl Hans | Mittel zur Beeinflussung von Störungen der Knochenbildung |
JP3250071B2 (ja) * | 1997-06-26 | 2002-01-28 | 株式会社ホーネンコーポレーション | 抗骨粗鬆症組成物 |
IT1299191B1 (it) * | 1998-06-23 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa |
US6150399A (en) * | 1998-06-30 | 2000-11-21 | Abbott Laboratories | Soy-based nutritional products |
JP2000191526A (ja) * | 1998-12-25 | 2000-07-11 | Marumiya:Kk | 骨形成促進及び抗骨粗鬆症組成物 |
WO2000069272A1 (en) * | 1999-05-18 | 2000-11-23 | Unilever N.V. | Fat containing products |
FR2817866B1 (fr) * | 2000-12-13 | 2005-01-07 | Theramex | Procede d'extraction de melanges flavoniques et utilisation des melanges ainsi obtenus en dermocosmetique, en alimentation et en pharmacie |
-
2002
- 2002-03-11 EP EP02726156A patent/EP1370257B1/en not_active Expired - Lifetime
- 2002-03-11 KR KR1020037012046A patent/KR100875800B1/ko active IP Right Grant
- 2002-03-11 AT AT02726156T patent/ATE367810T1/de not_active IP Right Cessation
- 2002-03-11 MX MXPA03008137A patent/MXPA03008137A/es active IP Right Grant
- 2002-03-11 WO PCT/EP2002/002646 patent/WO2002074308A1/en active IP Right Grant
- 2002-03-11 ES ES02726156T patent/ES2289097T3/es not_active Expired - Lifetime
- 2002-03-11 EP EP07014076A patent/EP1852115A1/en not_active Withdrawn
- 2002-03-11 CN CNB028066634A patent/CN100389765C/zh not_active Expired - Fee Related
- 2002-03-11 EP EP07014063A patent/EP1854462A1/en not_active Withdrawn
- 2002-03-11 CA CA2440261A patent/CA2440261C/en not_active Expired - Lifetime
- 2002-03-11 DE DE60221367T patent/DE60221367T2/de not_active Expired - Lifetime
- 2002-03-11 JP JP2002573015A patent/JP4646491B2/ja not_active Expired - Fee Related
- 2002-03-11 US US10/471,890 patent/US7635692B2/en not_active Expired - Fee Related
- 2002-03-11 BR BR0208103-2 patent/BRPI0208103B8/pt not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109527538A (zh) * | 2018-11-07 | 2019-03-29 | 云南金霓尔生物科技有限公司 | 一种治疗骨质疏松促进吸收的营养剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
US20040082523A1 (en) | 2004-04-29 |
CN100389765C (zh) | 2008-05-28 |
JP2004532829A (ja) | 2004-10-28 |
EP1370257A1 (en) | 2003-12-17 |
ATE367810T1 (de) | 2007-08-15 |
EP1370257B1 (en) | 2007-07-25 |
JP4646491B2 (ja) | 2011-03-09 |
BRPI0208103B1 (pt) | 2018-02-14 |
EP1854462A1 (en) | 2007-11-14 |
MXPA03008137A (es) | 2003-12-12 |
WO2002074308A1 (en) | 2002-09-26 |
EP1852115A1 (en) | 2007-11-07 |
CA2440261C (en) | 2014-05-27 |
BRPI0208103B8 (pt) | 2021-05-25 |
KR20040025906A (ko) | 2004-03-26 |
DE60221367D1 (de) | 2007-09-06 |
US7635692B2 (en) | 2009-12-22 |
KR100875800B1 (ko) | 2008-12-24 |
CA2440261A1 (en) | 2002-09-26 |
ES2289097T3 (es) | 2008-02-01 |
DE60221367T2 (de) | 2008-04-03 |
CN1501799A (zh) | 2004-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0208103A (pt) | Composição para a prevenção de osteoporose compreendendo uma combinação de isoflavonas e ácidos graxos poliinsaturados | |
BR9915687A (pt) | Composição compreendendo proteìna de soja,fibras de dieta e um composto fitoestrogênio eseu uso na prevenção e/ou tratamento de doençascardiovasculares | |
BRPI0316532B8 (pt) | composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável | |
BR9911440A (pt) | Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa | |
BR112022024943A2 (pt) | Composição oral efervescente compreendendo um ingrediente ativo | |
AR024516A1 (es) | Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica. | |
DE69916414D1 (de) | Sojazubereitungen und deren verwendung zur gesundheitsförderung | |
BR9711054A (pt) | Composições de carbohidratos de plantas como suplementos dietéticos. | |
BR9803251A (pt) | Agente de embranquecimento fluorescente | |
ECSP034732A (es) | Derivado de fenetanolamina para el tratamiento de enfermedades respiratorias | |
AR063555A1 (es) | Derivados de androstano, su uso en la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden y procesos para prepararlos | |
BR0114080A (pt) | Suplemento alimentìcio, uso do mesmo, método para auxiliar a prevenção ou tratamento de dano oxidativo, alimento, e, métodos para fabricar o mesmo, e para melhorar ou aumentar a produção de trabalho de um animal | |
ATE378058T1 (de) | Cannabis extrakten pharmazeutische zusammensetzung | |
MA27427A1 (fr) | Composes de benzimidazole-1-yl-thiophene utilises en cancerotherapie | |
BRPI0416292A (pt) | composições estabilizadas compreendendo probióticos | |
BRPI0416205A (pt) | uso de antibióticos como adjuvantes de vacina | |
BR0318411A (pt) | desinfetante mucoso não tóxico contendo álcool isopropìlico, óleo de gergelim, aloés e óleo de limão | |
BR0116179A (pt) | Composição despejável, processo de preparação de uma composição despejável e uso da composição | |
AR029795A1 (es) | Derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico sustituidos, procedimientos para su preparacion, su uso para la preparacion de medicamentos y medicamentos que contienen estos compuestos | |
GT199900081A (es) | Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos. | |
AR045911A1 (es) | Formulaciones auto-emulsionables y formulaciones auto-microemulsionables para la administracion oral de taxoides | |
BR0109139A (pt) | Composições farmacêuticas incluindo alginatos | |
BR9900820A (pt) | Processo para melhorar o nivelamento de um composição para polimento de piso, composição de polimento de piso, e, uso de cumarina. | |
BR9912816A (pt) | Composição terapêutica à base de flavonóides, tencionada para uso no tratamento de tumores por agentes citotóxicos | |
BR0207061A (pt) | Composição e método para o tratamento de lúpus e de doenças inflamatórias das articulações |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Free format text: DSM IP ASSETS B.V. (NL) |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 11/03/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 20A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2662 DE 11-01-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |